Tao Ning-Ning, He Xiao-Chun, Zhang Xian-Xin, Liu Yao, Yu Chun-Bao, Li Huai-Chen
Emerg Infect Dis. 2017 Nov;23(11):1800-1805. doi: 10.3201/eid2311.170234.
Microbial drug resistance has become a major public health concern worldwide. To acquire epidemiologic data on drug-resistant tuberculosis (DR TB) among children, a major cause of illness and death for this population, we conducted a retrospective study of 2006-2015 data from 36 TB prevention and control institutions in Shandong Province, China. A total of 14,223 new TB cases, among which children (<18 years of age) accounted for only 5.5%, were caused by culture-confirmed Mycobacterium tuberculosis. Among children with TB, 18.9% had DR TB and 6.9% had multidrug-resistant TB. Over the past decade, the percentage of DR TB; multidrug-resistant TB; and overall first-line drug resistance for isoniazid, rifampin, ethambutol, and streptomycin among children increased significantly (at least 12%). Understanding the long-term trends of DR TB among children can shed light on the performance of TB control programs, thereby contributing to global TB control.
微生物耐药性已成为全球主要的公共卫生问题。为获取儿童耐药结核病(DR-TB)的流行病学数据,DR-TB是该人群患病和死亡的主要原因之一,我们对中国山东省36家结核病防治机构2006年至2015年的数据进行了回顾性研究。共有14223例新结核病病例,其中儿童(<18岁)仅占5.5%,由培养确诊的结核分枝杆菌引起。在结核病儿童中,18.9%患有DR-TB,6.9%患有耐多药结核病。在过去十年中,儿童中DR-TB、耐多药结核病以及异烟肼、利福平、乙胺丁醇和链霉素的总体一线耐药率显著上升(至少12%)。了解儿童DR-TB的长期趋势有助于了解结核病控制项目的成效,从而推动全球结核病控制工作。